Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir in Mild COVID-19 Pneumonia
2020-002728-35Phase 3Completed
- Sponsor
- Hungarian Ministry of Innovation and Technology - Representative: Hecrin Consortium
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of favipiravir in coronavirus pneumonia and coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Hungarian Ministry of Innovation and Technology - Representative: Hecrin Consortium. Started Aug 2020; status: completed.
02
Drugs
favipiravir
03
Conditions
coronavirus pneumoniacoronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-002728-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002728-35.